By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sucampo Pharmaceuticals, Inc. 

4733 Bethesda Avenue
Suite 450
Bethesda  Maryland  20814  U.S.A.
Phone: 301-961-3400 Fax: 301-961-3440


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Publication of NICE Recommendation for AMITIZA(R) (Lubiprostone) 7/23/2014 12:48:33 PM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Second Quarter 2014 Financial Results And Corporate Update Teleconference And Webcast On August 5 7/22/2014 3:11:06 PM
Sucampo Pharmaceuticals, Inc. (SCMP) Release: Swissmedic Approves AMITIZA® (Lubiprostone) For The Treatment Of Opioid-Induced Constipation 7/8/2014 6:19:12 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Release: AMITIZA® (Lubiprostone) Receives National Institute for Clinical Excellence (NICE) Recommendation 6/18/2014 8:48:28 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Issues Statement Regarding Anesthetic and Analgesic Drug Products Advisory Committee Meeting's Vote 6/13/2014 8:09:39 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Webcast Of Its Presentation At 2014 Jefferies and Co. Global Healthcare Conference 5/29/2014 9:37:35 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Reports First Quarter 2014 Financial And Operating Results 5/8/2014 10:03:04 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces New Data On AMITIZA And Opioid-Induced Constipation Published Online In Pain Medicine Journal 5/6/2014 9:54:09 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Clinical Data On Lubiprostone To Be Presented At Two Upcoming Scientific Conferences 5/1/2014 9:19:29 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces First Quarter 2014 Results And Operating Highlights Teleconference And Webcast 4/30/2014 9:39:19 AM
12345678910...
//-->